Related references
Note: Only part of the references are listed.Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Heloise Ragelle et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology
Jianing Meng et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2017)
A Quality by Design Approach to Developing and Manufacturing Polymeric Nanoparticle Drug Products
Greg Troiano et al.
AAPS JOURNAL (2016)
Transforming Nanomedicines From Lab Scale Production to Novel Clinical Modality
Dalit Landesman-Milo et al.
BIOCONJUGATE CHEMISTRY (2016)
Boosting clinical translation of nanomedicine
Hae Lin Jang et al.
NANOMEDICINE (2016)
Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities
Vibhuti Agrahari et al.
THERAPEUTIC DELIVERY (2016)
Nanoparticles in the clinic
Aaron C. Anselmo et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2016)
Regulatory aspects on nanomedicines
Vanessa Sainz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy
Marina A. Dobrovolskaia
JOURNAL OF CONTROLLED RELEASE (2015)
Issues and concerns in nanotech product development and its commercialization
Indu Pal Kaur et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Organ-on-a-chip platforms for studying drug delivery systems
Nupura S. Bhise et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Engineering and evaluating drug delivery particles in microfluidic devices
Mattias Bjoernmalm et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Optimizing the discovery and clinical translation of nanoparticles: could microfluidics hold the key?
Jong-Min Lim et al.
NANOMEDICINE (2014)
Challenges in Development of Nanoparticle-Based Therapeutics
Neil Desai
AAPS JOURNAL (2012)
Challenges posed by the scale-up of nanomedicines
Madaswamy S. Muthu et al.
NANOMEDICINE (2012)
Microfluidic technologies for accelerating the clinical translation of nanoparticles
Pedro M. Valencia et al.
NATURE NANOTECHNOLOGY (2012)
FDA's Approach to Regulation of Products of Nanotechnology
Margaret A. Hamburg
SCIENCE (2012)
In vitro assessments of nanomaterial toxicity
Clinton F. Jones et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Toxic potential of materials at the nanolevel
A Nel et al.
SCIENCE (2006)
Share Paper
